eli lilly tirzepatide - Search News

India, Cipla and Lilly

InkFreeNews.com · 3h

Lilly Partners With Indian Pharmaceutical To Sell Rebranded Weight-Loss Drug

Eli Lilly and Co. has reached an agreement with pharmaceutical Cipla to market tirzepatide, the active ingredient in Lilly’s weight loss and Type 2 diabetes treatments, under a separate brand name in Cipla's home country of India.

Continue reading

· 2d · on MSN

Eli Lilly allows Cipla to sell weight loss drug under new brand in India

The Pharma Letter · 6h

Cipla and Eli Lilly partner to launch tirzepatide as Yurpeak in India

1d

Newsbreak Confirmed: What to make of Cipla's Yurpeak pact with Eli Lilly? Nuvama raises target by Rs 74

Eli Lilly's launch of Mounjaro in India in March 2025 was the first step of Tirzepatide in the country. In June 2025, the ...

3don MSN

3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results